Effects of continuous IV prostacyclin in a patient with pulmonary veno-occlusive disease

被引：35
作者：
Okumura, H
Nagaya, N
Kyotani, S
Sakamaki, F
Nakanishi, N
Fukuhara, S
Yutani, C
机构：
[1] Natl Cardiovasc Ctr, Dept Internal Med, Suita, Osaka 5658565, Japan
[2] Natl Cardiovasc Ctr, Dept Pathol, Suita, Osaka 5658565, Japan
来源：
CHEST | 2002年 / 122卷 / 03期
关键词：
prostacyclin; pulmonary veno-occlusive disease;
D O I：
10.1378/chest.122.3.1096
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
Pulmonary veno-occlusive disease (PVOD) is a rare but life-threatening disease. Although prostacyclin (PGI(2)) attenuates pulmonary hypertension and improves the prognosis in patients with primary pulmonary hypertension, little information is available regarding the effect of PGI(2) on patients with PVOD. This report describes a patient with severe PVOD who showed marked improvement in exercise capacity and pulmonary hemodynamics with continuous IV PGI(2) treatment. Furthermore, he experienced no clinical events for 12 months and survived for 25 months after the initiation of PGI(2) therapy. These results suggest that continuous IV PGI(2) therapy may serve as a bridge to transplantation in some cases of PVOD.
引用
收藏
页码：1096 / 1098
页数：3
相关论文
共 9 条
[1]   A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension [J].
Barst, RJ ;
Rubin, LJ ;
Long, WA ;
McGoon, MD ;
Rich, S ;
Badesch, DB ;
Groves, BM ;
Tapson, VF ;
Bourge, RC ;
Brundage, BH ;
Koerner, SK ;
Langleben, D ;
Keller, CA ;
Murali, S ;
Uretsky, BF ;
Clayton, LM ;
Jobsis, MM ;
Blackburn, SD ;
Shortino, D ;
Crow, JW .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (05) :296-301
[2]   PULMONARY VENOOCCLUSIVE DISEASE [J].
CHAWLA, SK ;
KITTLE, CF ;
FABER, LP ;
JENSIK, RJ .
ANNALS OF THORACIC SURGERY, 1976, 22 (03) :249-253
[3]   EFFECT OF PROSTACYCLIN ON MICROVASCULAR PRESSURES IN A PATIENT WITH PULMONARY VENOOCCLUSIVE DISEASE [J].
DAVIS, LL ;
DEBOISBLANC, BP ;
GLYNN, CE ;
RAMIREZ, C ;
SUMMER, WR .
CHEST, 1995, 108 (06) :1754-1756
[4]  
GREENBERG S, 1981, J PHARMACOL EXP THER, V219, P326
[5]   Pulmonary veno-occlusive disease - A case series and new observations [J].
Holcomb, BW ;
Loyd, JE ;
Ely, EW ;
Johnson, J ;
Robbins, IM .
CHEST, 2000, 118 (06) :1671-1679
[6]   Pulmonary veno-occlusive disease [J].
Mandel, J ;
Mark, EJ ;
Hales, CA .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (05) :1964-1973
[7]   Massive pulmonary edema and death after prostacyclin infusion in a patient with pulmonary veno-occlusive disease [J].
Palmer, SM ;
Robinson, LJ ;
Wang, AD ;
Gossage, JR ;
Bashore, T ;
Tapson, SF .
CHEST, 1998, 113 (01) :237-240
[8]   THE EFFECT OF HIGH-DOSES OF CALCIUM-CHANNEL BLOCKERS ON SURVIVAL IN PRIMARY PULMONARY-HYPERTENSION [J].
RICH, S ;
KAUFMANN, E ;
LEVY, PS .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (02) :76-81
[9]   CASE OF PULMONARY VENO-OCCLUSIVE DISEASE RESPONDING TO TREATMENT WITH AZATHIOPRINE [J].
SANDERSON, JE ;
SPIRO, SG ;
HENDRY, AT ;
TURNERWARWICK, M .
THORAX, 1977, 32 (02) :140-148
1